Defense: DOD & HHS Announce DPA Title III Agreement with Retractable Technologies, Inc. to expand domestic production capacity for low dead-space safety syringes and needles
Washington, may 25, 2021.- As part of the national response to COVID-19, the Department of Defense (DOD), in coordination with the Department of Health and Human Services (HHS), signed an agreement with Retractable Technologies, Inc. (RTI) to expand the production of the low dead-space (LDS) safety syringes and needles. GovernmentContinuar Leyendo















